 | Puma Biotechnology Inc (NASDAQ:PBYI) Expected to Post Earnings of -$0.76 Per Share
www.americanbankingnews.com - October 18 at 9:36 AM |
| Puma Biotechnology Inc (NASDAQ:PBYI) Sees Significant Drop in Short Interest
www.americanbankingnews.com - October 15 at 3:43 PM |
 | How Much Did Puma Biotechnology, Inc.'s (NASDAQ:PBYI) CEO Pocket Last Year?
finance.yahoo.com - October 10 at 3:53 PM |
| Goldman Recommends Selling Puma Biotech, Clovis Oncology; Cites Company-Specific, Competitive Risks
finance.yahoo.com - October 8 at 5:03 PM |
 | Here's Why Puma Biotechnology Tumbled Today
www.fool.com - October 8 at 12:03 PM |
| Puma Biotechnology (NASDAQ:PBYI) Downgraded to Sell at Goldman Sachs Group
www.americanbankingnews.com - October 8 at 9:15 AM |
| The Week Ahead In Biotech: Pfenex And Clinuvel On The Radar Ahead of FDA Decisions, 2 IPOs On Deck
finance.yahoo.com - October 6 at 10:07 PM |
 | Puma Stock Jumps as Biotech Gets Good News From the FDA
www.barrons.com - October 3 at 9:13 AM |
 | Puma Biotechnology: A Speculative Investment At A Discount
seekingalpha.com - October 2 at 4:45 PM |
| Puma Biotechnology +13% after FDA OKs Nerlynx label addition
seekingalpha.com - October 2 at 4:45 PM |
| Puma Biotechnology Inc (NASDAQ:PBYI) Given Consensus Rating of "Hold" by Brokerages
www.americanbankingnews.com - September 29 at 11:51 AM |
| Puma Biotechnology Inc (NASDAQ:PBYI) Expected to Announce Quarterly Sales of $60.93 Million
www.americanbankingnews.com - September 27 at 1:28 AM |
| Puma Biotechnology Inc (NASDAQ:PBYI) Expected to Announce Earnings of -$0.76 Per Share
www.americanbankingnews.com - September 25 at 8:50 PM |
| Insider Selling: Puma Biotechnology Inc (NASDAQ:PBYI) Insider Sells 1,711 Shares of Stock
www.americanbankingnews.com - September 25 at 7:03 PM |
 | Do Options Traders Know Something About Puma Biotech (PBYI) Stock We Don't?
www.msn.com - September 16 at 8:36 PM |
| Do Options Traders Know Something About Puma Biotech (PBYI) Stock We Don't?
finance.yahoo.com - September 16 at 4:26 PM |
| Puma Biotech's sNDA for Nerlynx Combo Gets FDA Acceptance
finance.yahoo.com - September 14 at 6:18 AM |
| FDA accepts Puma's application for expanded use of Nerlynx
seekingalpha.com - September 11 at 5:56 PM |
| Puma Biotechnology (NASDAQ:PBYI) Has Debt But No Earnings; Should You Worry?
finance.yahoo.com - September 11 at 5:56 PM |
| Puma Biotechnology Announces U.S. FDA Acceptance of Supplemental New Drug Application for Neratinib to Treat HER2-Positive Metastatic Breast Cancer
finance.yahoo.com - September 11 at 5:56 PM |
| Why Is Puma Biotech (PBYI) Up 16.8% Since Last Earnings Report?
finance.yahoo.com - September 8 at 7:58 AM |
| Puma Bio's Nerlynx OK'd in Argentina
seekingalpha.com - September 5 at 1:01 PM |
| Puma Biotechnology Licensing Partner Pint Pharma Receives Marketing Authorization for NERLYNX® (neratinib) for Extended Adjuvant Treatment of Early Stage Hormone Receptor Positive, HER2-Positive Breast Cancer
finance.yahoo.com - September 5 at 1:00 PM |
 | What This Recent FDA Move Could Mean for Breast Cancer Patients With Brain Metastases
247wallst.com - September 4 at 10:41 AM |
 | Puma's Breast Cancer Drug Accorded Orphan Drug Designation For Brain Metastases
www.benzinga.com - September 4 at 10:41 AM |
| Puma Bio up 9% on Orphan Drug tag for Nerlynx for certain breast cancer patients
seekingalpha.com - September 3 at 7:13 PM |
 | FDA Grants Orphan Drug Designation to Puma Biotechnology’s NERLYNX® for the Treatment of Breast Cancer Patients with Brain Metastases
www.businesswire.com - September 3 at 7:13 PM |
| Puma Biotech stock surges on FDA cancer drug designation
finance.yahoo.com - September 3 at 7:13 PM |
| Edited Transcript of PBYI earnings conference call or presentation 8-Aug-19 8:30pm GMT
finance.yahoo.com - August 14 at 7:11 PM |
 | Cellulite Treatment Market Projected To Reach $1,438.5 Billion By 2026
www.marketwatch.com - August 12 at 9:55 AM |
| Puma Biotechnology Inc (PBYI) Q2 2019 Earnings Call Transcript
www.fool.com - August 12 at 3:35 AM |
| Puma up 24% after hours on Q2 beat, Nerlynx sales up 6%
seekingalpha.com - August 8 at 8:01 PM |
 | Interesting PBYI Put And Call Options For March 2020
www.nasdaq.com - August 8 at 8:01 PM |
| Should You Be Worried About Insider Transactions At Puma Biotechnology, Inc. (NASDAQ:PBYI)?
finance.yahoo.com - August 8 at 8:01 PM |
| Puma Biotechnology Reports Second Quarter 2019 Financial Results
finance.yahoo.com - August 8 at 8:01 PM |
| Puma Biotechnology Q2 2019 Earnings Preview
seekingalpha.com - August 8 at 7:37 AM |
| Here's Why Puma Biotechnology Fell 24.1% in July
www.fool.com - August 8 at 7:37 AM |
| Here's Why Puma Biotechnology Fell 24.1% in July
finance.yahoo.com - August 8 at 7:37 AM |
| Puma Biotech (PBYI) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
finance.yahoo.com - August 1 at 7:53 PM |
| Keytruda data in TNBC modestly pressures Puma Bio, down 3%
seekingalpha.com - July 29 at 10:26 PM |
| Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
finance.yahoo.com - July 25 at 8:14 PM |
| Knight Therapeutics Announces Health Canada Has Approved NERLYNX ® for Early-Stage Breast Cancer
finance.yahoo.com - July 16 at 6:33 PM |
| Puma Bio up 5% after hours on Nerlynx nod in Canada
seekingalpha.com - July 16 at 6:33 PM |
| Knight Therapeutics Announces Health Canada Has Approved NERLYNX ® for Early-Stage Breast Cancer
finance.yahoo.com - July 16 at 6:33 PM |
| Puma Biotechnology’s Licensing Partner Knight Therapeutics Receives Regulatory Approval from Health Canada to Commercialize NERLYNX® (neratinib) for Extended Adjuvant Treatment of Hormone Receptor Positive, HER2-Positive Early Stage Breast Cancer
finance.yahoo.com - July 16 at 6:33 PM |
| Implied Volatility Surging for Puma Biotech (PBYI) Stock Options
finance.yahoo.com - July 5 at 5:46 PM |
| Puma Biotechnology Presents Interim Results from the Biliary Tract Cohort of its Phase II SUMMIT Basket Trial of Neratinib at the ESMO World Congress on Gastrointestinal Cancer 2019
finance.yahoo.com - July 3 at 6:09 PM |
| Puma Biotech Submits sNDA for Breast Cancer Drug Nerlynx
finance.yahoo.com - July 2 at 6:04 PM |
| Puma Bio files U.S. marketing application for expanded use of Nerlynx
seekingalpha.com - July 1 at 6:05 PM |
| Puma Biotechnology Submits a Supplemental New Drug Application to U.S. FDA for Neratinib to Treat HER2-Positive Metastatic Breast Cancer
finance.yahoo.com - July 1 at 9:03 AM |
